EUVIMEDObjevte EUVIMED
Open access · CC BY-NC 4.0

Melatonin inhibits atherosclerosis progression via galectin‐3 downregulation to enhance autophagy and inhibit inflammation

Zitong Wang, Ziyu Gao, Yinghong Zheng, Jiayuan Kou, Dan Song, Xue Yu, Bowen Dong, Tianzuo Chen, Yan Yang, Xi Gao, Qianxue Wang, Ting Ye and 4 more

Journal of Pineal Research · 2023

DOI: 10.1111/jpi.12855 ↗

At a glance

Journal article in Journal of Pineal Research, 2023. Written by Zitong Wang and 15 co-authors. Institution: Department of Pathophysiology, School of Basic Medical Sciences, Harbin Medical University, Harbin, China. Major MEDLINE topics: Melatonin, Atherosclerosis. Cited 62 times so far (Crossref); 43 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Key Discipline Construction Project of Harbin Medical University-Daqing, Key Laboratory of Myocardial Ischemia, Harbin Medical University, Ministry of Education, Heilongjiang Province Science Foundation for Distinguished Young Scholars.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Autophagy deficiency in macrophages exacerbates inflammation in atherosclerosis (AS), and recently, galectin‐3 (Gal‐3) has been implicated as a critical promoter of inflammation in AS. Further, melatonin (Mel) exerts an autophagy‐promoting effect in many chronic inflammatory diseases. In this study, we aimed to investigate whether Mel inhibits AS progression by downregulating Gal‐3 to enhance autophagy and inhibit inflammation. Thus, we performed in vivo and in vitro experiments using high‐fat diet (HFD)‐fed ApoE −/− mice and THP‐1 macrophages, respectively. Smart‐seq of AS plaque macrophages revealed that the differentially expressed genes (DEGs) downregulated by Mel were enriched in immune‐related processes, and changes in inflammation status were confirmed based on lower levels of proinflammatory factors in Mel‐treated HFD‐fed ApoE −/− mice and THP‐1 macrophages. Further, via transcriptome‐based multiscale network pharmacology platform (TMNP), the upstream target genes of the smart‐seq DEGs were identified, and Gal‐3 showed a high score. Gal‐3 was downregulated both in vivo and in vitro by Mel treatment. Besides, the enrichment of the target genes predicted via the TMNP method indicated that autophagy considerably affected the DEGs. Mel treatment as well as Gal‐3 knockdown downregulated most inflammatory response‐related proteins could attribute to enhancing autophagy. Mechanistically, Mel treatment inhibited Gal‐3 leading to lowering the activity of the nuclear transcription factor‐kappa B (NF‐κB) pathway, and promoting the nuclear localization of transcription factor EB (TFEB). However, increased secretion of Gal‐3 activated the phosphatidylinositol 3‐kinase (PI3K)/protein kinase B (AKT) pathway and impaired autophagy via binding to CD98. Thus, Mel promoted autophagy and restrained inflammation by downregulating Gal‐3, implying that it holds promise as a treatment for AS.

Subjects

MeSH terms (MEDLINE)

MelatoninAtherosclerosisAnimalsMiceGalectin 3Down-RegulationSignal TransductionPhosphatidylinositol 3-KinasesInflammationNF-kappa BAutophagyApolipoproteins E

Author keywords

CD98NF-κBPI3KTFEBautophagyinflammationmacrophages

Substances

Galectin 3MelatoninPhosphatidylinositol 3-KinasesNF-kappa BApolipoproteins E

Authors and institutions

  • Department of Pathophysiology, School of Basic Medical Sciences, Harbin Medical University, Harbin, China.
  • Science and Research Department, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of Biochemistry and Molecular Biology, Harbin Medical University, Harbin, China.
  • School of Public Health, Qiqihar Medical University, Qiqihar, China.
  • Department of Pathophysiology, Harbin Medical University (Daqing), Daqing, China.

Funding

  • Key Discipline Construction Project of Harbin Medical University-Daqing
  • Key Laboratory of Myocardial Ischemia, Harbin Medical University, Ministry of Education
  • Heilongjiang Province Science Foundation for Distinguished Young Scholars
  • Construction Project of Scientific Research and Innovation Team of Harbin Medical University-Daqing
  • National Natural Science Foundation of China

Cite

APA

Wang, Z., Gao, Z., Zheng, Y., Kou, J., Song, D., Yu, X., Dong, B., Chen, T., Yang, Y., Gao, X., Wang, Q., Ye, T., Yang, W., Zhang, X., Li, H., & Yang, L. (2023). Melatonin inhibits atherosclerosis progression via galectin‐3 downregulation to enhance autophagy and inhibit inflammation. Journal of Pineal Research. https://doi.org/10.1111/jpi.12855

Vancouver

Wang Z, Gao Z, Zheng Y, Kou J, Song D, Yu X, et al. Melatonin inhibits atherosclerosis progression via galectin‐3 downregulation to enhance autophagy and inhibit inflammation. Journal of Pineal Research. 2023. doi:10.1111/jpi.12855

BibTeX
@article{Wang2023,
  author = {Wang, Zitong and Gao, Ziyu and Zheng, Yinghong and Kou, Jiayuan and Song, Dan and Yu, Xue and Dong, Bowen and Chen, Tianzuo and Yang, Yan and Gao, Xi and Wang, Qianxue and Ye, Ting and Yang, Wei and Zhang, Xu and Li, Hong and Yang, Liming},
  title = {Melatonin inhibits atherosclerosis progression via galectin‐3 downregulation to enhance autophagy and inhibit inflammation},
  journal = {Journal of Pineal Research},
  year = {2023},
  doi = {10.1111/jpi.12855}
}
Start for free →